ArticleDiagnostics (Basel, Switzerland)2026

An Immunohistochemistry-Based Molecular Subtyping Approach for Capturing Clinical Outcome Heterogeneity in Bladder Cancer.

Yuhan Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.